Highlights
A collection of news and information related to Amgen Inc. published by this site and its partners.
Displaying items 1-12 of 100
» View herald-mail.com items only
1
2
3
4
5
6
7
8
9
Next >
-
Cynthia A. Maier, 54
Cynthia Anne Maier, 54, passed away Sunday, Sept. 16, 2012, at George Washington University Hospital. She had been hospitalized for treatment of chronic lymphocytic leukemia, which she had been struggling against for 16 years. Born July 6, 1958, in...
Tags: American Diabetes Association, Cedar Crest College, Lymphoma, Leukemia, Hagerstown (Washington, Maryland)
-
Lieuwe Westra wins Amgen Tour's first stage under brutal heat
ESCONDIDO, Calif. — Lieuwe Westra, red-faced and shaking, was the winner of Sunday's first stage at the Amgen Tour of California, on a day when temperatures on the route were recorded as high as 105 degrees. James Stemper, of the 5-hour Energy/...
Tags: Peter Sagan, Tour of California, Lieuwe Westra
-
Bill would regulate 'biosimilar' drugs
SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...
Tags: Pharmaceuticals, U.S. Senate Committee on Appropriations, Food and Drug Administration, Imports, Viral Diseases and Infections
-
Amgen at a glance
The company: Amgen Inc. Headquarters: Thousand Oaks Ticker: AMGN Employees: 18,000 Leadership: Robert A. Bradway, chief executive since May 2012 2012 revenue: $17.3 billion 2012 net income: $4.3 billion Stock price: $106.48 at Friday's close... -
Amgen aims to restock its medicine cabinet
Amgen Inc. is a biotechnology company that develops medicines used in the treatment of cancer, kidney disease, arthritis, bone disease and other serious illnesses. The Thousand Oaks company's top-selling products include arthritis medication Enbrel,...
Tags: Enbrel (drug), Biotechnology, Health Treatments, Pharmaceuticals, Diseases and Illnesses
-
A wife's Alzheimer's, a husband's obsession
Ken Chiate is a born problem-solver, and in the summer of 1961, when he was on break from college, his problem was a head-turning blond named Jeannette. He was head lifeguard at a public pool in Phoenix, where his father owned a liquor store. She worked...
Tags: Enbrel (drug), Science and Technology, Placebo, Health and Medical Professionals, University of California, Irvine
-
LETTER: ALEC too far right for these groups
The American Legislative Exchange Council (ALEC) is a group promoting far-right legislation. Its tax exempt status is currently challenged, as its sole purpose is to formulate legislation promoting extremely conservative points of view and helping the...Tags: CVS Corp., General Motors Corp., Merck & Company Incorporated, Bristol Myers Squibb Company, Bank of America Corp.
-
L.A. jury finds three guilty in $1.5-million Medicare fraud scheme
A federal jury in Los Angeles found an Anaheim physician and two others guilty this week for their roles in a $1.5-million Medicare fraud scheme involving power wheelchairs. At trial, federal prosecutors said that Godwin Onyeabor, 49, an officer at...Tags: General Practitioners, U.S. Department of Health and Human Services, Crime, Law and Justice, Drugs and Medicines, Prosecution
-
Amgen stock drops 7% as revenue misses Wall St. forecasts
Shares of biotech giant Amgen Inc. slumped as investors reacted to weaker-than-expected first-quarter sales. Shares of the Thousand Oaks company dropped $7.83, or 7%, to $104.93 in trading Wednesday. The company's stock had posted impressive gains until...
Tags: Enbrel (drug), Rheumatoid Arthritis
-
Shares of biotech giant Amgen slide on disappointing sales
Shares of biotech giant Amgen Inc. slumped Wednesday as investors reacted to weaker-than-expected first-quarter sales. Shares of the Thousand Oaks company dropped $6.41, or nearly 6%, to $106.35 in trading Wednesday. The company's stock had posted...
Tags: Enbrel (drug), Rheumatoid Arthritis
-
The day ahead in business April 23
Reports: PMI manufacturing index flash for April, 7:58 a.m.; FHFA housing price index for February, 8 a.m.; New home sales for March, 9 a.m.; Richmond Fed manufacturing index for April, 9 a.m. Local earnings: Anixter International Inc., DeVry Inc.,...
Tags: Gannett Company, Inc., Molex Incorporated, Johnson Controls Incorporated, Unisys Corporation, United Technologies Corporation
-
Letters: Medicare and Amgen
Re "Remove Medicare's straitjacket," Opinion, March 29 Art Kellerman misunderstands why Congress delayed inclusion of oral-only drugs in the Medicare payment bundle for dialysis services. It wasn't to give Amgen and other drug makers a major windfall;...Tags: Oral and Maxillofacial Surgeons, Dialysis, Government Health Care, Health and Medical Professionals, Medicare
Sep 19, 2012
|Story| Herald Mail
May 12, 2013
|Story| Los Angeles Times
May 12, 2013
|Story| Los Angeles Times
May 6, 2013
|Story| Los Angeles Times
May 6, 2013
|Story| Los Angeles Times
May 5, 2013
|Story| Los Angeles Times
Apr 29, 2013
|Story| Aberdeen News
Apr 26, 2013
|Story| Los Angeles Times
Apr 24, 2013
|Story| Los Angeles Times
Apr 24, 2013
|Story| Los Angeles Times
Apr 23, 2013
|Story| Chicago Tribune
Apr 11, 2013
|Story| Los Angeles Times
Original site for Amgen Inc. topic gallery.
